Suman Adhikari

Suman Adhikari

Auto-generated profile, based on publicly available information

Suman Adhikari

Department of Internal Medicine, Pokhara Academy of Health Sciences, Pokhara, Nepal

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2004 in Annals of Emergency Medicine
Verified
Journal Article
Closed access
CCC.M. Cannon
C.M. Cannon
RBR.N. Bilkowski
R.N. Bilkowski
SAS. Adhikari
S. Adhikari
INI. Nasr
I. Nasr

25 March 2023 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
RPRajendra Poudel
Rajendra Poudel
SBSurakshya Baral
Surakshya Baral
SASuman Adhikari
Suman Adhikari
UDUmesh Dhungana
Umesh Dhungana
APAshesh Pradhan
Ashesh Pradhan
SHSurya Bahadur Hamal
Surya Bahadur Hamal
Introduction: Thyrotoxic periodic paralysis (TPP) is a rare complication of hyperthyroidism characterized by episodes of muscle weakness and hypokalemia. Patients may present with a sudden onset of muscle weakness. Though hyperthyroidism occurs more commonly in females, TPP typically occurs in young males in their third decade. Case Presentation: This is a case of a 32-year-old male who presented to the emergency room with a sudden onset of weakness in bilateral upper and lower limbs, which progressed to complete paralysis in an hour. A provisional diagnosis of hypokalemic periodic paralysis was made and admitted. Later, on further diagnostic workup, the final diagnosis of TPP was made. Discussion: Clinical features of hyperthyroidism in patients with TPP may be subtle. With immediate potassium supplementation, serious cardiopulmonary complications can be prevented and may hasten the recovery of muscle weakness. Nonselective β-adrenergic blockers can lessen and prevent the recurrence of paralytic attacks. Conclusion: This case is reported with the objective of generating awareness regarding the clues to the diagnosis, appropriate management, and definitive treatment to a render euthyroid state in order to prevent future recurrence of similar episodes and prevent any complications, and eventually to raise the index of suspicion among treating physicians in cases that present with paralysis in clinical practice.

6 May 2020 in Nepalese Heart Journal
Verified
Journal Article
Open access
PDF file
SASuman Adhikari
Suman Adhikari
RGRatna Mani Gajurel
Ratna Mani Gajurel
CPChandra Mani Poudel
Chandra Mani Poudel
HSHemanta Shrestha
Hemanta Shrestha
STSanjeev Thapa
Sanjeev Thapa
MSManju Sharma
Manju Sharma
Background and Aims: Heart failure is one of the debilitating conditions in patients with various forms of heart disease. It can have impacts on various aspects of the life of a patient. There have been few studies on the etiological aspects and precipitants of heart failure in the Nepalese population. The aim of our study is to find out the major factors that lead to decompensation of heart failure in patients who already have established heart failure. Methods: This study was a single-centre, prospective, observational study conducted in the emergency department of Manmohan Cardiothoracic Vascular and Transplant Centre (MCVTC) from 1st June 2019 to 30th November 2019. Hundred and one patients with established heart failure in the past, who presented again with decompensated heart failure were enrolled. Results: The mean age of the patients was 62.81 years (SD=15.92). Factors responsible for acute decompensation of heart failure were identified in 95.0 % of patients included in the study. The most common factor identified was poor compliance with medications and diet and fluid intake (38.6%). Next to it was arrhythmia identified in about 35.6% of cases.Other important factors responsible for decompensation in our study were infection (12.8%), anemia (4.9%) and ischemia (2.9%). Conclusion: Preventable and identifiable factors are responsible for the decompensation of heart failure. Most of these factors can be modified with the use of proper patient counseling/patient education, thereby reducing recurrent hospital admissions and economic burden to the patient and the government as well.

5 November 2020 in Nepalese Heart Journal
Verified
Journal Article
Open access
PDF file
SASuman Adhikari
Suman Adhikari
RGRatna Mani Gajurel
Ratna Mani Gajurel
CPChandra Mani Paudel
Chandra Mani Paudel
SDSurya Devkota
Surya Devkota
SSSmriti Shakya
Smriti Shakya
VYVijay Yadav
Vijay Yadav
The overall incidence of embolic complications in infective endocarditis (IE) ranges from 20 to 50%. It is very uncommon for a treating physician to encounter a patient having multiple manifestations of systemic embolisation.Acute coronary syndrome complicating infective endocarditis is an uncommon finding and the incidence has been found to be upto 10%.Cerebral embolism should be suspected in patients with infective endocarditis and neurological sign and symptoms. Neurologic manifestations can sometimes be the first presentation of infective endocarditis. We present the scenario of a 51-year-old diabetic male with chronic kidney disease, rheumatic heart disease with infective endocarditis leading to multiple embolic complications. Our case is notable because the patient had evidence of coronary, cerebral, splenic, hepatic and musculoskeletal manifestations due to embolic complications of IE within a duration of one year. Our case was primarily managed by multidiscipliniary approach. It is an impossible task for a cardiologist to treat such cases with showering complications where a multidisciplinary team approach is the only treatment option.

30 October 2025 in Nepalese Heart Journal
Verified
Journal Article
Open access
PDF file
SASuman Adhikari
Suman Adhikari
RPRajendra Poudel
Rajendra Poudel
STSurya Bahadur Hamal Thakuri
Surya Bahadur Hamal Thakuri
SBShankar Baral
Shankar Baral
CNChoodamani Nepal
Choodamani Nepal
VMVarsha Manandhar
Varsha Manandhar
Background and aims: One important residual CVD risks is elevated level of lipoprotein a (Lp(a)). High Lp(a) level is atherogenic. It’s higher prevalence in South Asian population is important because of a higher prevalence of premature coronary artery disease in younger population of this region. Lp(a) testing is underutilized. Knowing elevated levels in an individual may help address and control traditional risk factors of ASCVD in such patients. Methods: This study was an observational, prospective study carried out in the department of internal medicine, Pokhara Academy of Health Sciences(POAHS), Nepal. The study was started on 17th September 2023 and completed on 16th March 2024. The details of history and the physical examination of cases were recorded in the proforma designated for the study. Baseline data were recorded including age, sex, presence of risk factors like diabetes mellitus(DM), hypertension(HTN), dyslipidemia, smoking, history of CAD (coronary artery disease) and coronary revascularization, family history of premature CAD, lab parameters like blood glucose, lipid profiles, Lp(a), ECG, echocardiography, coronary angiography. Statistical analysis was carried out with the help of the latest version of SPSS. Results: The mean age was 48.52 years (SD=9.06). Majority were (56%) male patients. 42 cases (84%) were dyslipidemics and 26 (52%) were hypertensives, 10 cases (20%) had family history of coronary artery disease in first degree relatives, 10(20%) had coronary artery disease, eight (16%) had DM, two (4%) were smokers. Elevated Lp(a) (>/=50mg/dl) was found in 14(28%) of total cases. Of total cases, Lp(a) was /=20 mg/ dl was observed in 40% of cases. Conclusion: The prevalence of elevated Lp(a) in Nepalese patients with traditional risk factors of ASCVD is high. These findings from our study may carry important implications for clinical practice in Nepal. Performing targeted screening in high-risk individuals may help redefine risk category and may help in aggressively managing traditional risk factors

31 December 2018 in Journal of Advances in Internal Medicine
Verified
Journal Article
Open access
PDF file
SASuman Adhikari
Suman Adhikari
RMRewati Raman Malla
Rewati Raman Malla
MSManoj Shah
Manoj Shah
AUAnanta Upreti
Ananta Upreti
BTBhawesh Thapa
Bhawesh Thapa
EBV infection can occur worldwide. We managed a 17 year old male who developed transient pancytopenia followed by thrombocytosis concurrent with EBV infection. To the best of our knowledge we have not encountered any cases of thrombocytosis concurrent with EBV infection before. Our case was diagnosed as a case of EBV infection with the help of serology and managed conservatively. In our case, though it is uncommon to find thrombocytosis due to EBV infection, it is possible that following pancytopenia concurrent with the EBV infection, the patient might have developed secondary or reactive thrombocytosis due to elevated endogenous levels of thrombopoietin, interleukin-6, catecholamines.